Enhance biomedical insight generation by improving data quality How do you know if your bio-molecular data is high quality? It is an axiom that bad data is costly. This is as true for bio-molecular data as it is for anything else. Drug discovery teams often complain about ?bad ' data but do not have the language to describe it. White Paper A l f r e d S u s a n E l i n a Bioinformatics scientist at a big Pharma company Biologist at a mid-size Pharma company Bioinformatics scientist at an early-stage company Alfred has spent 2 weeks analyzing data from a single cell experiment only to find out later that the right controls were never in place. What an unproductive activity! Susan is looking for a study done by her colleague who has left. She is unable to retrieve the data. No keywords work

Join for free to read